Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin)

Links shared publicly online about this topic.

  • 1,721
    total visits

Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin)

medicalnewstoday.com

Merck & co., inc., which operates in many countries as merck sharp & dohme (msd), has received a positive opinion from the european medicines agency's (emea) committee for medicinal products for h

View full resource at medicalnewstoday.com

Tags: Diabetes Type 2 Medication, Januvia, Merck & Co.

  • Share

Most Recently Shared on September 26, 2009 at 2:10 pm By:

mnt_diabetes MNT Diabetes News

Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin): Merck & C.. http://bit.ly/4KL2j

3 years ago...

Also Shared By:

MNT Clinical Trials MNT Clinical Trials

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

news-medical.net — “Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 5:41 pm By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype ... http://bit.ly/lnRTSV

11 months ago...

Merck Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA(R)

medicalnewstoday.com — “Merck & Co., Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injectioView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 21, 2009 at 1:15 pm By:

mnt_fertility MNT Fertility News Health News

Merck Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA(R): Merck & Co., Inc. announced the Co.. http://bit.ly/08Gx5RL

2 years ago...

Merck & Co., Inc. Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) - News, Search Jobs, Events

biospace.com — “Merck & Co., Inc. Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) - News, Search Jobs, EventsView full resource at biospace.com

  • View Related
  • Share

Most Recently Shared on November 20, 2009 at 3:25 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

RT @Biotechnology: Merck & Co., Inc. Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) : http://bit.ly/2I9JB0

2 years ago...

Merck Receives Positive CHMP Opinion For JANUVIA(R) (sitagliptin) And JANUMET(R) (sitagliptin/metformin) As Add-On To Insulin In The European Union

medicalnewstoday.com — “Merck & co., inc., which operates in many countries as merck sharp & dohme (msd), has received a positive opinion from the european medicines agency's (emea) committee for medicinal products for hView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 28, 2009 at 2:08 pm By:

mnt_diabetes MNT Diabetes News Health News

Merck Receives Positive CHMP Opinion For JANUVIA(R) (sitagliptin) And JANUMET(R) (sitagliptin/metformin) As Add.. http://bit.ly/kuFvK

3 years ago...

Advertisement